Search Results 1141-1150 of 18505 for Prednisone

1. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection - Mayo Clinic

   Corticosteroid use at daily doses higher than 20 mg of prednisone equivalent within 14 days prior to randomization, with the exception of inhaled or topical ...

2. A Study to Evaluate the Safety and Effectiveness of AK002 in Patients with Active Eosinophilic Gastritis - Mayo Clinic

   Use of systemic or topical corticosteroids exceeding the equivalent of 10 mg/day of prednisone within 4 weeks prior to the screening visit. Change in the ...

3. A Study of MT-5111 in HER2-positive Solid Tumors - Mayo Clinic

   Current evidence of hypersensitivity requiring systemic steroids at doses > 20 mg/d prednisone equivalent. History or current evidence of any other medical ...

4. Monoamine oxidase inhibitors (MAOIs) - Mayo Clinic

   These antidepressants may help if other treatments fail. If you take them, stay away from certain foods and medicines to prevent serious side effects.

5. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   Oral corticosteroids equivalent to ≤ 10 mg/day prednisone if started at least ≤ 2 weeks prior to randomization. Inhaled and topical corticosteroids are ...

6. Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients with Chronic Rhinosinusitis and Nasal Polyps - Mayo Clinic

   However, patients on chronic steroids equal to ≤ 20 mg of prednisone daily, are eligible. Patients who were on a different biologic medication in the ...

7. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   ... prednisone at steady dose >10 mg/day or equivalent. Current alcohol or substance abuse in the opinion of the investigator. Pregnant, breastfeeding, or ...

8. Lenalidomide or Observation in Treating Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   ... prednisone 10 mg per day; Prior or concurrent topical or localized glucocorticosteroid therapy to treat non-malignant comorbid disorders is permitted ...

9. A Study to Evaluate the Safety and Effectiveness of Bimagrumab on Improvement in Total Lean Body Mass and Physical Performance Following Surgical Treatment of Hip Fracture. - Mayo Clinic

   ... prednisone equivalent; Currently enrolled in a clinical trial involving an investigational drug or off label use of a drug; Discontinued within the last 30 ...

10. Pertuzumab-dpzb (intravenous route) - Side effects & uses - Mayo Clinic

    Pertuzumab-dpzb injection is used in combination with other cancer medicines (eg, trastuzumab, docetaxel) to treat HER2-positive metastatic (cancer that has ...